Robert Kramer - President and CEO, Emergent Biosolutions Inc
As of May 11, 2021
Robert Kramer Net Worth
- Net worth is estimated to be at least $26.83M
- Owns at least 139,210 units of Emergent Biosolutions Inc stock
- Sold an estimated value of $20.12M in the last 15 years at Emergent Biosolutions Inc
Robert Kramer Compensation at Emergent Biosolutions Inc in 2020
- Earned a $893,860 salary
- Rewarded $2,050,007 in stock value and options
- Received a total compensation of $5,569,978
Robert Kramer Trading
- Largest purchase of shares was 45,397 units , worth over $1.4M on February 9, 2021
- Largest sale of shares was 45,397 units , worth over $5.45M on February 9, 2021
- In total has made about 47 transactions over 15 years
- Usually trades in June, with the busiest year in 2007
Robert Kramer
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Robert Kramer Mailing Address
- Mailing address is 2273 Research Blvd, Suite 400 Rockville MD 20850 MD
Emergent Biosolutions Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Fuad El-Hibri | 2020 | $1,192,202 | $1,200,046 | $815,051 | - | $6,185 | $3,213,484 |
| Fuad El-Hibri | 2019 | $1,131,577 | $1,099,949 | $773,813 | - | $4,723 | $3,010,062 |
| Fuad El-Hibri | 2018 | $1,047,031 | $957,456 | $957,481 | - | $8,250 | $2,970,218 |
| Robert Kramer | 2020 | $893,860 | $2,050,007 | $1,392,416 | $1,225,020 | $8,675 | $5,569,978 |
| Robert Kramer | 2019 | $678,021 | $1,439,958 | $1,012,999 | $557,108 | $5,735 | $3,693,821 |
| Robert Kramer | 2018 | $549,047 | $649,930 | $649,980 | $538,807 | $8,983 | $2,396,747 |
| Richard Lindahl | 2020 | $549,390 | $749,998 | $509,425 | $462,012 | $10,475 | $2,281,300 |
| Richard Lindahl | 2019 | $514,826 | $619,984 | $436,154 | $297,429 | $9,104 | $1,877,497 |
| Richard Lindahl | 2018 | $365,393 | $557,438 | $351,101 | $330,007 | $8,514 | $1,612,453 |
| Adam Havey | 2020 | $546,507 | $700,047 | $475,413 | $445,204 | $8,357 | $2,175,528 |
| Adam Havey | 2019 | $484,120 | $619,984 | $436,154 | $279,579 | $25,530 | $1,845,367 |
| Adam Havey | 2018 | $480,728 | $499,974 | $359,784 | $310,212 | $8,383 | $1,659,081 |
| Atul Saran | 2020 | $528,803 | $700,047 | $475,413 | $445,204 | $9,565 | $2,159,032 |
| Atul Saran | 2019 | $503,774 | $619,984 | $436,154 | $293,567 | $9,500 | $1,862,979 |
| Atul Saran | 2018 | $488,730 | $527,475 | $379,572 | $293,567 | $8,683 | $1,698,027 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1367644/000136764421000061/ebsi2021asmproxystatement.htm
Emergent Biosolutions Inc Insider Trading
- The most recent transaction was 3,139 units sold on May 27, 2021 by Kathryn Zoon worth over $177.29K
- In the last 15 years, insiders at Emergent Biosolutions Inc sold an estimated value of $236.88M and bought an estimated value of $38.53M
- The most active traders are Fuad Elhibri, Chairman, Daniel Abdunnabi, CEO, and Robert Kramer, President and CEO
- Insider trading is most common in May, with the busiest year in 2007
Emergent BioSolutions Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||